| Document |
Document Title |
|
WO/2023/176736A1 |
The present invention addresses the problem of providing a novel bisphenol compound that has a further improved refractive index. Provided is a 1,3-bis(1-methyl-1-phenylethyl)benzene compound represented by general formula (1).
|
|
WO/2023/177449A1 |
Process for producing phenol, cresol and xylenes from a coal-derived feed are described. The processes combine dealkylation of alkylphenols from coal derived liquids followed by benzene and/or toluene transalkylation to reduce the produc...
|
|
WO/2023/169921A1 |
The present invention discloses a method for extracting cannabidiol from milled and decarboxylated hemp using subcritical liquid carbon dioxide and for converting the extracted cannabidiol to tetrahydrocannabinol using supercritical carb...
|
|
WO/2023/167325A1 |
The present invention addresses the problem of developing a metal catalyst which is suitable for continuous flow organic synthesis reaction, is excellent in durability, and has high activity. The present invention provides an immobiliz...
|
|
WO/2023/163026A1 |
The purpose of the present invention is to provide a bisphenol production method in which, using a highly-versatile catalyst, a polycarbonate resin is decomposed with a high level of reactivity to produce bisphenol. Provided is a bisph...
|
|
WO/2023/159095A1 |
The present disclosure provides a detergent additives and methods for preparing a sulfurized alkyl phenate product from polyalphaolefins.
|
|
WO/2023/150347A2 |
Cannabinoid derivatives may exhibit anti-inflammatory properties such as by inhibition of cannabinoid type 2 (CB2) receptors. Pharmaceutical compositions comprising the cannabinoid derivatives may be used to treat various diseases and co...
|
|
WO/2023/147665A1 |
The present disclosure relates to compositions for improving gut health and/or milk production in ruminants, comprising: at least one organic acid chosen from sorbic acid, fumaric acid, malic acid, lactic acid, citric acid, formic acid, ...
|
|
WO/2023/143158A1 |
The present invention relates to a phenol derivative, a crystal form thereof, and a preparation method therefor, in particular to a solid intermediate used for preparing the phenol derivative, and specifically provides a compound shown i...
|
|
WO/2023/137548A1 |
The present document describes a livestock dietary supplement composition which comprises a sialagogue comprising cinnamaldehyde, an anti-inflammatory comprising a salicylate, an expectorant comprising menthol, an antimicrobial comprisin...
|
|
WO/2023/133483A1 |
The application relates to recombinant polypeptides having berberine bridge enzyme (BBE) activity that are derived from microorganisms, such as Phytohabitans suffuscus, Streptomyces sp. AJS327, Streptomyces varsoviensis, Actinomadura pel...
|
|
WO/2023/124881A1 |
The present invention relates to a visible-light-mediated one-step method for preparing phenol and cyclohexanone from cyclohexylbenzene (CHB). The method specifically comprises: under the irradiation of visible light, and with a hydrogen...
|
|
WO/2023/116193A1 |
Disclosed in the present invention are a method preparing an antibacterial antioxidant and the use thereof, which belong to the field of fine chemicals. In the present invention, α-phellandrene and phloroglucinol are used as raw materia...
|
|
WO/2023/115220A1 |
A combination comprising tilorone/nelfinavir; tilorone/molnupinavir; tilorone/remdesivir; tilorone/alfacalcidol; tilorone/clofazimine; tilorone/danazol; tilorone/manidipine; tilorone/sertraline; tilorone/trifluoperazine; remdesivir/hexac...
|
|
WO/2023/115116A1 |
The present invention relates to polynucleotides for the generation of genetically modified plants, algae or plastids thereof that are capable of producing cannabinoids. In an aspect, the present invention also relates to methods of prod...
|
|
WO/2023/109859A1 |
Provided are a compound as shown in formula (I) or a pharmaceutically acceptable salt thereof. The compound can efficiently penetrate a blood-brain barrier, inhibit an inflammatory response of the central nervous system, can be used for ...
|
|
WO/2023/110711A1 |
The present invention relates to a method for the manufacture of a core-shell catalyst comprising the steps of a. providing core particles, b. functionalizing at least part of the surface of the core particles with a functionalizing agen...
|
|
WO/2023/111488A1 |
The invention relates to a process for producing 2,6-diisopropyl phenol. The process comprises a step of decarboxylation of 4-hydroxy-3,5-diisopropylbenzoic acid or a salt thereof in an aqueous medium under pressure.
|
|
WO/2023/108277A1 |
The present invention relates to application of hydrotropic agents in making water-soluble and super-fast disintegrating tablets, buccal tablets, or sublingual tablets containing either cannabinoid molecules or psychedelics molecules. Th...
|
|
WO/2023/103611A1 |
The present invention belongs to the field of the synthesis of fine chemical intermediates, and discloses a bromopyrene intermediate and derivatives thereof, a preparation method, and use. The bromopyrene intermediate has a molecular str...
|
|
WO/2023/108098A1 |
In one aspect, the disclosure relates to axially chiral cannabinoid analogs and methods of making the same. In one aspect, several tetracyclic scaffolds can be prepared from O-propargyl vinyl coumarins in good yields. In a further aspect...
|
|
WO/2023/104159A1 |
The present invention relates to compounds as calcium channel blocker, a composition comprising thereof, use of said compounds and a method for treating diseases or disorders associated with calcium ion channel using said compounds. The ...
|
|
WO/2023/100138A1 |
Self-emulsifying drug delivery compositions are provided for oral delivery of cannabinoids. The cannabinoids are dissolved in a solubilizer together with at least one stabilizer to improve dissolution and stability. The cannabinoids are ...
|
|
WO/2023/100867A1 |
The purpose of the present invention is to provide a methyl methacrylate–containing composition that has high stability of quality when stored. According to the present invention, a methyl methacrylate–containing composition includes...
|
|
WO/2023/095568A1 |
[Problem] To provide a method for producing hydroxytyrosol from olive leaves, and a hydroxytyrosol-containing composition. [Solution] This method for producing hydroxytyrosol from olive leaves includes a step for pressurized hot water ex...
|
|
WO/2023/090298A1 |
One embodiment of the method for producing a cyclic compound of the present invention is characterized by having a step for obtaining a cyclic compound by applying, to a starting material containing a cyclic carboxylic acid compound, a h...
|
|
WO/2023/077234A1 |
The present invention relates to methods of immune modulation. In particular, the present invention relates to regulation of neuroinflammation by modulation of ABCF1. Modulation of ABCF1 may be useful in the MDD.
|
|
WO/2023/074450A1 |
A clathrate compound that is obtained by mixing an (A) imidazole compound and a (B) polyvalent phenol compound, said clathrate compound having an average particle size (X) of 7 μm or less and a maximum particle size (Y) of 40 μm or les...
|
|
WO/2023/063973A1 |
Processes for producing cresol from an alkylphenol stream involve transalkylating the longer-chain alkylphenols (i.e., having an alkyl chain with 2 or more carbon atoms) with an aromatic solvent such as benzene and/or toluene in a first ...
|
|
WO/2023/061999A1 |
The present invention discloses a distinct mode of action of a nickel catalyst to forge C-0 bonds to unlock the mild utilization of N2O as O-atom transfer reagent in the synthesis of complex phenols from the corresponding aryl halides.
|
|
WO/2023/058524A1 |
The present invention provides: a compound which can exhibit a high refractive index; and an application of said compound. One embodiment of the present invention relates to a compound represented by formula (1). R1 is a hydrogen ato...
|
|
WO/2023/053043A1 |
A topical cannabinoid composition, kit and method for pain relief is provided. The composition comprises cannabinoids selected from CDB, THC, CBN, THCV and CBN and a base composition. The base composition may be a cream or balm type. Som...
|
|
WO/2023/047194A1 |
Disclosed is a system (100) and process (200) for continuous preparation of meta-cresol. The system (100) may comprise one or more components such as a gas mixing unit (101), a reactor unit (102) connected to a coiled reactor (103), a di...
|
|
WO/2023/043197A1 |
The present invention provides a cannabidiol derivative, a method for preparing same, and a composition for cognitive function improvement comprising same. The novel cannabidiol derivative of the present invention has been confirmed to e...
|
|
WO/2023/042993A1 |
An embodiment of the present invention provides a method for preparing hydrogenated bisphenol A comprising the steps of:(a) heating a reactor into which bisphenol A, a solvent, and a ruthenium-supported catalyst are added; (b) causing a ...
|
|
WO/2023/043149A1 |
An apparatus for predicting an amount of dust, according to one embodiment of the present invention, predicts the amount of dust generated in a process for generating BPA prills from liquid BPA flowing into a prill tower, the apparatus f...
|
|
WO/2023/035071A1 |
A cannabinoid-humic substances composition is provided. The cannabinoid-humic substances composition includes a cannabinoid and humic substances perforated by voids. The cannabinoid is complexed with humic substances and fixed in the voi...
|
|
WO/2023/038156A1 |
The present invention relates to compounds of the formula (I) where X is selected from the group consisting of a single bond, O, N-(C1-C4)-alkyl, N-Ar1, CR5R6, S, S(O) and SO2; Z1 and Z2 are independently selected from hydrogen, -Alk-OH,...
|
|
WO/2023/033165A1 |
A compound represented by formula [I] (in the formula, R12, R13, R14, R15 and R16 are the same or different, and are hydrogen, halogen, a C1-6 alkyl optionally substituted with halogen, or a C1-6 alkoxy optionally substituted with haloge...
|
|
WO/2023/021472A1 |
In one embodiment, the present invention describes a method for identifying an optimized natural medicine containing defined doses of active and contributing ingredients. In one embodiment, the method disclosed in the present invention d...
|
|
WO/2023/015629A1 |
Provided is a method for preparing phloroglucinol from 2,4,6-triaminotoluene. The method comprises: using 2,4,6-triaminotoluene and a hydrochloride thereof as raw materials to carry out hydrolysis-isomerization reaction of trienamine to ...
|
|
WO/2023/017128A1 |
The present invention relates to a novel process for preparing cresol from ditolylether.
|
|
WO/2023/012691A1 |
The present disclosure relates to the transdermal administration of pharmaceutical agents, such as CBD, THC, psilocybin, psilocin, lysergic acid diethylamine (LSD), and/or ibogaine, and derivatives of these compounds, for the treatment a...
|
|
WO/2023/010390A1 |
Process for the production of phenol, said process comprising the steps of:(A) producing ethanol from a biomass, which is advantageously a carbohydrate-containing biomass, then(B) causing the ethanol produced at the step (A) to react wit...
|
|
WO/2023/011634A1 |
The present invention relates to a benzo-ring-containing derivative, and a preparation method therefor and the use thereof. Specifically, the present invention relates to a compound as represented by general formula (Ia), and a preparati...
|
|
WO/2023/009876A1 |
Methods of improving the stability of a non-petroleum oil using cannabinoid compounds are described herein. The cannabinoid compounds can include cannabigerol ("CBG") and/or cannabigerolic acid ("CBGA"). The cannabinoid compounds can be ...
|
|
WO/2023/008355A1 |
According to the present invention, it is possible to provide a resist auxiliary film composition comprising: a resin (A); and a solvent (B) containing a compound (B1) represented by general formula (b-1), wherein the content of an activ...
|
|
WO/2023/008705A1 |
The present invention relates to a method for mass production of a high content of cannabidiol (CBD) from Cannabis sativa L. Considering that, by decarboxylating a raw material as it is without extracting C. sativa L., a high content of ...
|
|
WO/2023/008354A1 |
The present invention provides a resist composition which contains a resin (A) and a solvent (B) containing a compound (B1) represented by general formula (b-1), and which contains an active ingredient in an amount of 45 mass% or less wi...
|
|
WO/2023/285509A1 |
The present invention relates to a process for the preparation of a compound having formula (I) wherein R is selected from the group consisting of: halogen, (C1-C6)alkoxy, (C1-C6)alkyl, halo(C1-C6)alkyl, and halo(C1-C6)alkoxy, said proce...
|
